| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |